AuroraCoins broker reveals 5 best stocks to look out for in 2022

preview_player
Показать описание
#AuroraCoins #AuroraCoinsReviews

Aurora-Coins broker, david Sorkin, has revealed 5 best stocks to look out for in 2022, and these stocks are selected according to his research and long-term investments. These stocks are proven success stories in the stock market. Currently, they did an incredible climb up the investment ladder in 2017-2018. It will be interesting to watch these companies develop in the coming years. These stocks are some of the most profitable companies globally, and their success is expected to continue for years to come.
Aurora-Coins broker picked out these 5 stocks as they believe they will make phenomenal results for investors in 2022.
1) NVIDIA Corporation
2) Regeneron Pharmaceuticals, Incorporated
3) Freeport-McMoRan Incorporated (FCX)
4) Netflix, Incorporated
5) Advanced Micro Devices Incorporated
1. NVIDIA Corporation
According to analysts polled by Thomson Reuters, the price of NVIDIA has risen 27% and is expected to hit $400 in 2022. That would be roughly a 13% annual pace over the next five years.
NVIDIA Corporation engages in the design, manufacture, and sale of computer hardware and software products for the gaming industry. The price of NVIDIA has risen 27% since its IPO in 1999, beating S&P 500's return by 11 percentage points. NVDA currently trades at $212 with a P/E ratio of 43.47x, the highest among the five stocks.
NVIDIA has been a powerhouse in the hardware and gaming industry for many years. They continue to produce innovative products that revolutionize the industry. Their stock has seen steady growth over the past few years and is expected to continue this trend into the future. They have a strong team of employees dedicated to their success and a passionate fanbase that supports their products. NVIDIA is a well-established company with a proven track record and is worth investing in.
Regeneron Pharmaceuticals, Incorporated (REGN)
The price of Regeneron has risen 51% and is expected to hit $810 in 2022, according to analysts polled by Thomson Reuters. That would be roughly a 26% annual pace over the next five years.
Regeneron Pharmaceuticals, Incorporated engages in the discovery, development, and commercialization of medicines to treat serious medical conditions in North America, Europe, and Asia using biotechnology. The price of Regeneron has risen 51% since its IPO in 1988, beating S&P 500's return by 12 percentage points. REGN currently trades at $553 with a P/E ratio of 22.25x, the second highest among the five stocks.
Regeneron Pharmaceuticals is a world-class company that produces innovative products for its customers. They have been expanding into new markets and developing groundbreaking medicines to help those who need them most. The medical field has seen many changes over the years, and Regeneron has been at its forefront. They consistently provide their customers with superior treatments and make breakthroughs in medicine. REGN is a well-established company with a proven track record and is worth investing in.
Freeport-McMoRan Incorporated (FCX)
According to analysts polled by Thomson Reuters, the price of Freeport-McMoRan has risen 50% and is expected to hit $50 in 2022. That would be roughly a 5% annual pace over the next five years.
Freeport-McMoRan Incorporated engages in mineral exploration, development, production, processing, smelting, refining, fabricating, and marketing. The price of Freeport-McMoRan has risen 50% since its IPO in 1994, beating S&P 500's return by one percentage point. FCX currently trades at $15 with a P/E ratio of -569x, the lowest among the five stocks.
Freeport-McMoRan Incorporated is a company made up of one of the best teams in the industry. They can identify strong investment opportunities and make them into profitable ventures. Freeport-McMoRan has built its reputation on solid financials, management expertise, and scale economics. FCX is a well-established company with a proven track record and is worth investing in.
Netflix, Incorporated (NFLX)
According to analysts polled by Thomson Reuters, the price of Netflix has risen 621% and is expected to hit $550 in 2022. That would be roughly a 25% annual pace over the next five years.
Netflix, Incorporated engages in the Internet delivery of TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally. The price of Netflix has risen 621% since its IPO in 2002, beating S&P 500's return by 361 percentage points. NFLX currently trades at $329 with a P/E ratio of 81.03x, the highest among the five stocks.
Netflix is a well-established company that revolutionized media streaming services. They offer an affordable and convenient service that has completely changed the industry. Netflix continues developing and innovating their business model and bringing great content to their customers while doing so. NFLX is a well-established company with a proven track record and is worth investing in.
Рекомендации по теме